Integrin Expression and IgA Nephropathy: in Vitro Modulation by IgA with Altered Glycosylation and Macromolecular IgA
Overview
Authors
Affiliations
Background: Signal transduction by mesangial cell (MC) integrins regulates cell growth and survival, extracellular matrix production, and organization. The aim of the study was to investigate human MC integrin modulation by differently glycosylated IgA and macromolecular IgA, which are thought to play a pathogenetic role in IgA nephropathy (IgAN).
Methods: MCs were incubated with purified human polymeric IgA, heat-aggregated IgA, IgA glycoforms generated by enzymatic hydrolysis of saccharide residues and serum fractions from IgAN patients, and controls isolated by lectin affinity and containing IgA with peculiar glycan patterns. Integrins were quantitated by flow cytometry.
Results: Cultured MCs highly expressed alphavbeta3 and some alpha3beta1; alphavbeta3 was up-regulated by matrix components (P < 0.02). In vitro desialylated and degalactosylated polymeric human IgA enhanced alphavbeta3 expression on cultured MCs (P < 0.001). Serum IgA glycoforms isolated from IgAN patients with high exposure of internal sugars, GalNAc, Neu5Ac2,6GalNAc, and Man enhanced alphav expression on cultured MCs more than healthy controls. CONCLUSIONS.: These data support the hypothesis that IgA glycation plays a role in modulating the cell-matrix interaction, and that this mechanism can be operating in IgAN.
The Feasibility of Targeted Magnetic Iron Oxide Nanoagent for Noninvasive IgA Nephropathy Diagnosis.
Wu Y, Huang Q, Wang J, Dai Y, Xiao M, Li Y Front Bioeng Biotechnol. 2021; 9:755692.
PMID: 34900958 PMC: 8656216. DOI: 10.3389/fbioe.2021.755692.
C4d deposits in IgA nephropathy: where does complement activation come from?.
Coppo R Pediatr Nephrol. 2017; 32(7):1097-1101.
PMID: 28197885 DOI: 10.1007/s00467-016-3575-2.
IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.
Xue J, Zhu L, Wei Q Glycoconj J. 2013; 30(8):735-45.
PMID: 23783413 DOI: 10.1007/s10719-013-9481-y.
Inoue T, Sugiyama H, Kitagawa M, Takiue K, Morinaga H, Ogawa A PLoS One. 2012; 7(3):e33965.
PMID: 22457806 PMC: 3311555. DOI: 10.1371/journal.pone.0033965.
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
Narita I, Gejyo F Clin Exp Nephrol. 2008; 12(5):332-338.
PMID: 18404247 DOI: 10.1007/s10157-008-0054-5.